作者：
Rebecca L,Mather [1]
;
Abhijit,Parolia [2]
;
Sandra E,Carson [2]
;
Erik,Venalainen [3]
;
David,Roig-Carles [1]
;
Mustapha,Jaber [2]
;
Shih-Chun,Chu [2]
;
Ilaria,Alborelli [4]
;
Rebecca,Wu [3]
;
Dong,Lin [3]
;
Noushin,Nabavi [5]
;
Elena,Jachetti [6]
;
Mario P,Colombo [3]
;
Hui,Xue [7]
;
Perla,Pucci [7]
;
Xinpei,Ci [3]
;
Cheryl,Hawkes [1]
;
Yinglei,Li [5]
;
Hardev,Pandha [6]
;
Igor,Ulitsky [1]
;
Crystal,Marconett [8]
;
Luca,Quagliata [9]
;
Wei,Jiang [10]
;
Ignacio,Romero [11]
;
Yuzhuo,Wang [4]
;
Francesco,Crea [8]
作者单位：
Cancer Research Group-School of Life Health and Chemical Sciences, The Open University, Milton Keynes, UK.
[1]
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
[2]
Experimental Therapeutics, BC Cancer Research Centre, Vancouver, Canada.
[3]
Institute of Pathology, University Hospital Basel, Switzerland.
[4]
The Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, Canada.
[5]
Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
[6]
Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
[7]
Medical Research Institute, School of Medicine, Wuhan University, Wuhan, China.
[8]
Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey, Guildford, UK.
[9]
Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
[10]
Departments of Surgery, Biochemistry and Molecular Medicine, Norris Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
[11]
DOI
10.1002/1878-0261.12954
PMID
33793068
发布时间
2022-05-31
换一批
换一批
